Meeting
2020 ASCO Virtual Scientific Program
Clinical outcomes and economic burden for bladder cancer patients: An analysis from a Swedish cancer registry.
Authors
Joaquim Bellmunt
Beth Israel Deaconess Medical Center, Boston, MA
Joaquim Bellmunt , Thomas Powles , Roger Henriksson , Gary D. Steinberg , Nurgul Batyrbekova , Frida Schain , Sarah Fleming , Waleed Shalaby , Arlene O. Siefker-Radtke
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Bladder Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 5026)
DOI
10.1200/JCO.2020.38.15_suppl.5026
Abstract #
5026
Poster Bd #
95
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma.
First Author: Shruthi Naik
Poster
2022 ASCO Genitourinary Cancers Symposium
Identification of muscle-invasion status in bladder cancer patients using natural language processing and machine learning.
First Author: Ruixin Yang
Poster
2020 Genitourinary Cancers Symposium
Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath study.
First Author: Nicholas D. James
Poster
2018 Genitourinary Cancers Symposium
Evaluating cell cycle progression score as a prognostic marker for non-muscle invasive bladder cancer (NMIBC).
First Author: Christopher J. Weight